US Broker Ratings

Celcuity Inc. (CELC) Stock Analysis: A Biotech Gem with 131% Upside Potential

Celcuity Inc. (NASDAQ: CELC) is gaining significant attention in the biotechnology sector, not just for its cutting-edge research in cancer therapies but also for its promising..

InnovAge Holding Corp. (INNV) Stock Analysis: A Closer Look at Growth Potential Amidst Market Fluctuations

InnovAge Holding Corp. (NASDAQ: INNV) is a player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.24 billion,..

Upstream Bio, Inc. (UPB) Stock Analysis: A 584.46% Upside Potential in the Biotech Space

Upstream Bio, Inc. (UPB), a clinical-stage biotechnology company, has caught the attention of investors with a staggering potential upside of 584.46%, according to the latest analyst..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 202% Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the biotechnology sector, has recently caught the attention of investors due to its promising potential for substantial..

Claritev Corporation (CTEV) Stock Analysis: Exploring an 89% Upside Potential

Investors with an eye on the healthcare sector may find Claritev Corporation (CTEV) particularly intriguing, especially given its impressive potential upside of 89.07%. Operating within the..

SIGA Technologies Inc. (SIGA) Stock Analysis: Insight into Current Challenges and Opportunities

Investors eyeing SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector, are met with a mixed bag of financial metrics that warrant a..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Navigating Biotech’s Potential with a 38.94% Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology innovator, is capturing the attention of investors with its cutting-edge approach to developing antibody-based medicines. Despite the recent..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 541% Potential Upside Amidst Biotech Advances

Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors, not just for its innovative approach in the biotech sector, but also for its eye-catching potential..

REGENXBIO Inc. (RGNX) Investor Outlook: Unpacking a 191.51% Potential Upside

REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector with a promising prospect for investors seeking substantial growth potential. This clinical-stage company, headquartered in Rockville,..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges Amidst Biotechnology Innovation

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) sits at the intersection of biotechnology and innovation, offering a compelling yet challenging landscape for investors. As a trailblazer in..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Exploring a 37.65% Potential Upside

Sonida Senior Living, Inc. (SNDA) is a prominent player in the healthcare sector, focusing on medical care facilities specifically tailored for senior housing communities in the..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Biotech’s Potential with an 8.65% Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands at the intersection of biotechnology and innovation, offering investors a unique opportunity within the healthcare sector. With a market..

EyePoint, Inc. (EYPT) Stock Analysis: Uncovering a Potential 648.82% Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is catching the attention of investors with a staggering potential upside of 648.82%, according to analyst ratings. Despite its current challenges, this..

AtaiBeckley Inc. (ATAI) Stock Analysis: An Insight into the Biotech Innovator’s 10.43% Potential Upside

AtaiBeckley Inc. (NASDAQ: ATAI) presents a compelling opportunity for investors seeking exposure to the innovative and rapidly evolving field of mental health treatments. With its robust..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 263% Upside in the Biotech Arena

Humacyte, Inc. (NASDAQ: HUMA) is capturing the attention of investors with its groundbreaking biotechnology solutions and a remarkable potential upside of 263.45%. As a pioneer in..

Standard BioTools Inc. (LAB): Investor Outlook on a Potential 101% Upside in Medical Devices

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with a promising potential upside of..

RxSight, Inc. (RXST) Stock Analysis: Potential 56% Upside and Strategic Position in Medical Devices

RxSight, Inc. (NASDAQ: RXST) is capturing the attention of investors with its cutting-edge technology in the healthcare sector, specifically within the medical devices industry. Based in..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges in the Diagnostics & Research Sector

For investors keeping a close eye on the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents both challenges and potential opportunities. Operating in the diagnostics and..

Cronos Group Inc. (CRON) Stock Analysis: Strong Revenue Growth but Analysts Cautious with Target Ratings

Cronos Group Inc. (NASDAQ: CRON), a major player in the healthcare sector and a notable member of the specialty and generic drug manufacturers industry, is drawing..

Capricor Therapeutics (CAPR) Stock Analysis: Exploring a Potential 237.08% Upside in the Biotech Sector

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is emerging as a noteworthy player in the biotechnology sector, particularly for investors seeking exposure to innovative healthcare solutions. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds